Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Sporos Bioventures

Investor type Venture Capital
Founders Alex Cranberg Dana Levy Joseph Kekst Louis Feinberg Peter Feinberg


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 5
Average round size
The average size of a deal this fund participated in
Portfolio companies 4
Rounds per year 5.00
Lead investments 0
Follow on index
How often the fund supports its portfolio startups at next rounds
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Biopharma
  • Therapeutics

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sporos Bioventures:
Typical Co-investors
Sporos Bioventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sporos Bioventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
China Post Beijing, Beijing, China
Fangde Zhilian Investment China, Guangdong, Shenzhen
Fomou Assets -
Glass Capital Management New Jersey, Saddle River, United States
Golzern Holding GmbH -
Haodao Capital -
Investissement Desjardins Canada, Montréal, Quebec
Latin Idea Ventures Distrito Federal, Mexico, Mexico City
Latour Capital France, Ile-de-France, Paris
Leeh Capital China, Hangzhou, Zhejiang
Leonis Investissement -
Pocket University China, Jiangsu, Suzhou
RSM Investments -
Spiegel Capital Management California, San Diego, United States
Tianjin Woda Guquan Touzi -
Tomato Bank Japan, Okayama, Okayama Prefecture
Yara ventures -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Tvardi Therapeutics

Health Care
$72M15 Jun 2021 Houston, Texas, United States

Stellanova Therapeutics

$15M03 Jun 2021 Houston, Texas, United States

Asylia Therapeutics

Health Care
$14M25 May 2021 Houston, Texas, United States

Nirogy Therapeutics

$16M26 Jan 2021 Massachusetts, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sporos Bioventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: